Positron Emission Tomography (PET) Market Size & Growth Forecast 2027–2036, By Segments (Product Type, Detector Type, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Positron Emission Tomography Market size was around USD 2.32 Billion in 2026 and is slated to grow at 6.47% CAGR from 2027 to 2036, reaching USD 4.34 Billion by 2036. The industry revenue for 2027 is assessed at USD 2.45 Billion.
Get more details on this report
Request Free Sample ReportPositron Emission Tomography (PET) Market Intelligence Snapshot
Regional Market Dynamics
- North America leads through advanced nuclear medicine infrastructure, sophisticated imaging adoption, specialized centers, strong healthcare expenditure, and established clinical capabilities across major applications.
- Europe is growing fastest due to rising demand for advanced diagnostics, expanding molecular imaging, healthcare investment, improved nuclear medicine infrastructure, and personalized treatment strategies.
Segment Momentum
- Hospitals led the market in 2026 because they offer advanced imaging infrastructure, comprehensive diagnostic services, and integrated PET applications across oncology, neurology, and cardiology, supported by ongoing technology investments.
- Silicon photomultiplier (SiPM) detectors are expected to grow the fastest, driven by their ability to improve image resolution, sensitivity, imaging efficiency, and support next-generation PET system development.
Market Expansion Drivers
- Rising demand for advanced diagnostic imaging accelerating PET-CT hybrid system adoption
- Technological advancements in radiopharmaceutical imaging improving diagnostic accuracy and efficiency
- Expanding use of PET imaging in oncology and neurology driving clinical demand growth
Leading Market Participants
- Major players in the positron emission tomography market include Siemens Healthineers AG (Germany), GE HealthCare Technologies Inc. (USA), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan), United Imaging Healthcare Co., Ltd. (China), Mediso Ltd. (Hungary), Neusoft Medical Systems Co., Ltd. (China), Molecubes NV (Belgium), Oncovision S.A. (Spain)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 2.32 Billion
- 2027 Estimated Market Size: USD 2.45 Billion
- Projected Market Size: USD 4.34 Billion by 2036
- Growth Forecast: 6.47% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Europe
- Core Revenue Segment: Full Ring PET Scanner (Product Type) | Lutetium Oxyorthosilicate (LSO) (Detector Type) | Hospitals (End Use)
- Emerging Opportunity Segment: Full Ring PET Scanner (Product Type) | Silicon Photomultiplier (SiPM) (Detector Type) | Diagnostic Centers (End Use)
Market Growth Drivers and Industry Trends
Rising demand for advanced diagnostic imaging accelerating PET-CT hybrid system adoption
Healthcare providers are increasingly adopting sophisticated imaging technologies to improve disease detection, treatment planning, and patient management across a broad range of clinical conditions. This trend will drive the positron emission tomography market growth as PET-CT hybrid systems combine metabolic and anatomical imaging into a single examination, enabling more comprehensive diagnostic evaluations. Hospitals and diagnostic centers are prioritizing integrated imaging platforms that reduce diagnostic uncertainty while supporting more informed clinical decision-making. The ability to streamline workflows and provide detailed visualization of disease activity has strengthened the preference for hybrid imaging systems in routine clinical practice.
Technological advancements in radiopharmaceutical imaging improving diagnostic accuracy and efficiency
Continuous innovation in radiotracer development, detector technology, image reconstruction software, and scanner performance is enhancing the clinical capabilities of molecular imaging. The positron emission tomography market benefits from these technological improvements by enabling higher image quality, faster scanning procedures, and more precise visualization of physiological processes. Advances in imaging technology also support improved lesion detection, optimized workflow efficiency, and expanded diagnostic applications across multiple medical specialties. These developments allow clinicians to obtain more detailed functional information while improving the overall efficiency of imaging services.
Expanding use of PET imaging in oncology and neurology driving clinical demand growth
The growing clinical application of PET imaging in cancer diagnosis, neurological disorders, and disease monitoring is expanding its role within modern healthcare. As a result, the positron emission tomography market continues to experience stronger demand from hospitals and specialized imaging centers seeking advanced tools for disease characterization and treatment assessment. In oncology, PET imaging assists clinicians in staging disease, evaluating therapeutic response, and detecting recurrence, while neurological applications support the assessment of conditions affecting brain function and metabolism. The increasing reliance on functional imaging for personalized clinical decision-making has broadened the utilization of PET across diverse patient care pathways.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising demand for advanced diagnostic imaging accelerating PET-CT hybrid system adoption | 2% | High | North America, Europe | High | Near Term |
| Technological advancements in radiopharmaceutical imaging improving diagnostic accuracy and efficiency | 1.8% | High | Europe, Asia Pacific | High | Mid Term |
| Expanding use of PET imaging in oncology and neurology driving clinical demand growth | 1.7% | High | North America, Asia Pacific | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the positron emission tomography (PET) market in 2026, supported by advanced nuclear medicine infrastructure, high adoption of sophisticated diagnostic imaging technologies, and strong healthcare expenditure. The region benefits from the availability of specialized imaging centers, experienced healthcare professionals, and established clinical capabilities for oncology, cardiology, and neurological applications. Growing demand for accurate disease detection and treatment planning is also encouraging the use of PET imaging, while continued investments in healthcare infrastructure and imaging technology are strengthening the region's position. Increasing integration of PET with complementary imaging modalities is further improving diagnostic capabilities and supporting broader clinical utilization.
Europe (Fastest-Growing Region)
Europe is expected to register the fastest growth, driven by increasing demand for advanced diagnostic procedures and expanding use of molecular imaging across healthcare systems. Growing emphasis on early disease detection, particularly for cancer and neurological disorders, is encouraging healthcare providers to adopt PET-based diagnostic approaches. Public healthcare investments, improvements in nuclear medicine infrastructure, and broader access to sophisticated imaging services are also supporting regional expansion. In addition, the increasing focus on personalized treatment strategies is creating greater demand for functional and molecular imaging technologies capable of providing detailed information for diagnosis, disease monitoring, and treatment selection.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Precision Oncology DiagnosticsThe U.S. PET market is strongly driven by oncology applications and advanced diagnostic imaging in large hospital networks. Adoption of next-generation tracers and hybrid PET/CT systems is expanding, supported by investments in early disease detection and personalized treatment planning.
Germany 🇩🇪
Advanced Imaging InfrastructureGermany prioritizes high-resolution PET imaging systems integrated into comprehensive diagnostic pathways. Hospitals emphasize clinical accuracy, standardized imaging protocols, and integration with oncology and neurology treatment workflows.
Japan 🇯🇵
Aging Population Imaging DemandJapan’s PET market is shaped by aging demographics and rising need for early cancer and neurodegenerative disease detection. Healthcare providers invest in compact systems and radiotracer innovations to improve diagnostic throughput and patient accessibility.
South Korea 🇰🇷
AI-Enabled Imaging SystemsSouth Korea is advancing PET adoption through AI-assisted imaging analysis and digital hospital integration. Providers focus on improving diagnostic speed and precision while expanding hybrid imaging capabilities across major medical centers.
France 🇫🇷
Public Healthcare Imaging ExpansionFrance supports PET adoption through public healthcare investment in advanced diagnostic imaging networks. Demand is concentrated in oncology and cardiology, with emphasis on standardized access and efficient imaging utilization across regional hospitals.
Italy 🇮🇹
Hospital Imaging ModernizationItaly is upgrading hospital-based imaging infrastructure with PET systems to improve early disease detection. Focus remains on expanding access in public hospitals while improving workflow efficiency and diagnostic accuracy.
Segment Leadership and Growth Trends
Positron Emission Tomography (PET) Market Share (%), Product Type, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Type Segment Analysis: Full Ring PET Scanner (Largest & Fastest-Growing Segment)
The positron emission tomography market was dominated by the full ring PET scanner segment, accounting for 79.28% in 2026, while also being the fastest-growing product type. Full ring PET scanners are extensively adopted because they provide superior image sensitivity, improved diagnostic accuracy, and shorter scanning times compared with alternative system designs. Their ability to support precise disease detection and comprehensive clinical evaluations has made them the preferred choice across advanced imaging facilities. Continued technological advancements and increasing demand for high-quality molecular imaging are expected to sustain the segment’s leading position.
Detector Type Segment Analysis: Lutetium Oxyorthosilicate (LSO) (Largest Segment) vs Silicon Photomultiplier (SiPM) (Fastest-Growing Segment)
The lutetium oxyorthosilicate (LSO) detector segment accounted for 37.26% of the market in 2026, reflecting its established role in PET imaging systems. LSO detectors are widely utilized because of their high light output, rapid signal response, and reliable imaging performance, enabling accurate lesion detection and efficient diagnostic workflows. Their proven clinical effectiveness and compatibility with modern PET systems continue to support widespread adoption across healthcare facilities.
The positron emission tomography market is witnessing the fastest growth in the silicon photomultiplier (SiPM) detector segment due to increasing demand for advanced detector technologies that deliver enhanced image resolution and greater sensitivity. SiPM technology supports improved signal detection, compact system design, and higher imaging efficiency, making it increasingly attractive for next-generation PET platforms. Ongoing innovation in medical imaging equipment and the growing focus on early disease diagnosis continue to drive adoption of this detector technology.
End Use Segment Analysis: Hospitals (Largest Segment) vs Diagnostic Centers (Fastest-Growing Segment)
Hospitals held the largest share of the market in 2026, supported by their comprehensive diagnostic capabilities, availability of specialized imaging infrastructure, and ability to manage complex patient care. The integration of PET imaging into multidisciplinary clinical services, including oncology, neurology, and cardiology, has strengthened the position of hospitals as the primary end users of these systems. Continuous investment in advanced diagnostic technologies further reinforces their market leadership.
Diagnostic centers represent the fastest-growing end-use segment in the positron emission tomography market, driven by rising demand for specialized imaging services and greater accessibility to advanced diagnostic procedures. These facilities are increasingly expanding their imaging capabilities to provide timely and efficient diagnostic evaluations while supporting growing outpatient healthcare needs. The increasing preference for dedicated diagnostic services continues to contribute to the rapid expansion of this segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product Type | Partial Ring PET Scanner, Full Ring PET Scanner | Full Ring PET Scanner | Full Ring PET Scanner |
| Detector Type | Lutetium Oxyorthosilicate (LSO), Silicon Photomultiplier (SiPM), Lutetium Yttrium Orthosilicate (LYSO), Digital Photon Counters (DPC), Others | Lutetium Oxyorthosilicate (LSO) | Silicon Photomultiplier (SiPM) |
| End Use | Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Others | Hospitals | Diagnostic Centers |
Competitive Landscape and Market Positioning
Key companies in the positron emission tomography (PET) market:
- Siemens Healthineers AG (Germany)
- GE HealthCare Technologies, Inc. (USA)
- Koninklijke Philips N.V. (Netherlands)
- Canon Medical Systems Corporation (Japan)
- Fujifilm Holdings Corporation (Japan)
- United Imaging Healthcare Co., Ltd. (China)
- Mediso Ltd. (Hungary)
- Neusoft Medical Systems Co., Ltd. (China)
- Molecubes NV (Belgium)
- Oncovision S.A. (Spain)
The positron emission tomography (PET) market is increasingly competitive as imaging providers focus on advancing diagnostic precision, workflow efficiency, and integration with modern healthcare infrastructure. Manufacturers are moving beyond scanner performance improvements by emphasizing solutions that enhance clinical decision-making and accommodate growing demand for personalized diagnostic approaches. Competitive advantage is shifting toward technological adaptability, including improved imaging capabilities and software-driven enhancements that support complex clinical applications. Providers able to combine innovation with dependable service support are strengthening their role as healthcare systems seek more efficient imaging solutions.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Lantheus Holdings, Inc. | Jun-26 | Lantheus received a Complete Response Letter from the U.S. FDA regarding its New Drug Application for the LNTH-2501 PET imaging kit. The regulatory setback delays the commercialization of the somatostatin receptor-positive neuroendocrine tumor diagnostic pending resolution of agency observations. |
| Lantheus | Mar-26 | Lantheus secured U.S. FDA approval for Pylarify TruVu, broadening the clinical utility of its established prostate cancer PET imaging agent. The regulatory milestone improves diagnostic access for recurrent or metastatic disease while fortifying the company's oncology market share. |
| Heavy Water Board | Jan-26 | The Heavy Water Board reached a critical production milestone for Oxygen-18 enriched water, an essential raw material for producing fluorine-18 radiopharmaceuticals. This scaling of domestic manufacturing capacity enhances supply chain security for PET imaging markets. |
| Curium Pharma | Apr-25 | Curium Pharma finalized the acquisition of Eczacıbaşı-Monrol Nuclear Products. The deal directly scales Curium's radiopharmaceutical manufacturing footprint and reinforces its competitive capabilities across global nuclear medicine and PET imaging supply chains. |
| GE HealthCare | Apr-25 | GE HealthCare expanded its molecular diagnostics footprint by acquiring the remaining stake in Nihon Medi-Physics. The transaction consolidates its control over regional radiopharmaceutical operations and strengthens its portfolio of PET and SPECT imaging agents. |
| DuChemBio | Apr-25 | DuChemBio submitted a new drug application in South Korea for Posluma, a PET diagnostic imaging agent for prostate cancer. The filing represents a critical commercialization milestone as the company seeks entry into the Korean molecular imaging market. |
| Lantheus Holdings, Inc. | Jan-25 | Lantheus Holdings announced an agreement to acquire Life Molecular Imaging Ltd. for an upfront cash payment and milestone considerations. The acquisition integrates the approved imaging agent NeuraCeq into Lantheus' portfolio, strengthening its positioning in the PET radiopharmaceutical segment. |
| Positron | Nov-24 | Positron entered into a strategic commercial partnership with Upbeat Cardiology Solutions to deploy its NeuSight PET-CT 64-slice scanner. The collaboration expands Positron's cardiac imaging presence and enhances its competitive positioning in high-end diagnostic care. |
| GE HealthCare | Sep-24 | The U.S. FDA granted approval for GE HealthCare's flurpiridaz F-18 PET radiotracer designed for coronary artery disease imaging. The regulatory clearance introduces a highly differentiated myocardial perfusion agent, advancing the company's cardiovascular molecular imaging pipeline. |
| Siemens Healthineers | Aug-24 | Siemens Healthineers agreed to acquire the radiopharmaceutical molecular imaging manufacturing and distribution network of Novartis. This strategic transaction significantly expands the company's production infrastructure and enhances its capacity to deliver PET imaging products globally. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Positron Emission Tomography (PET) Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Clinical Indication | Oncology, Cardiology, Neurology, Other Clinical Applications |
| Radiotracer Type | Fluorine-18-Based Tracers, Carbon-11-Based Tracers, Gallium-68-Based Tracers, Rubidium-82-Based Tracers, Other Radiotracers |
| Service Model | Capital Equipment Sales, Equipment Leasing, Managed Imaging Services, Pay-Per-Scan Services |
Positron Emission Tomography (PET) Market — report.custom
| Custom Chapter | Custom Details |
|---|---|
| Diagnostic Imaging Infrastructure Gap Assessment |
|
| Radiopharmaceutical Supply Network Evaluation |
|
| Clinical Adoption Pathway Analysis by Disease Area |
|
Need a different cut of the data?
Request Custom ResearchHow much revenue does the positron emission tomography (PET) market generate?
What is the projected value of the positron emission tomography industry by 2036?
Why are PET-CT hybrid systems becoming a strategic investment for healthcare providers?
How are technological advancements expanding the clinical value of PET imaging?
Why do hospitals account for the largest share of the PET market?
Which detector technology is expected to grow the fastest in the PET market?
Why does North America dominate the PET market?
What is driving faster PET market growth in Europe?
What are the prominent companies operating in the positron emission tomography landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization